Geneva, July 14 -- International Clinical Trials Registry received information related to the study (ACTRN12625000692437) titled 'Evaluating the effect of iStent infinite on glaucoma and dry eye disease' on July 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: Glaukos Corporation
Condition:
Glaucoma
Dry Eye
Glaucoma
Dry Eye
Eye - Diseases / disorders of the eye
Intervention:
iStent infinite and dry eye reduction in ocular hypertension (OHT) and open angle glaucoma (OAG) patients with premium intraocular lenses (IOL)
Participants are adult patients with OHT or mild-to-moderate (gr...